This final brief in a series about ISAs explores the current state of the income share agreement market and highlights opportunities and threats to expansion.
Deliberating the pros and cons of medical evidence to govern treatment decisions decreases the public’s willingness to rely solely on patient choices, especially when those choices can harm the individual or the larger community.